The founding team combines over 60 years of leadership expertise across the life sciences sector, from startups to global corporations

We put our customers first, understanding that every weight loss journey is unique. Science shows there's a powerful connection between gut health and weight management. That's why we focus on supporting your gut health while you're taking weight loss medications like Ozempic, Wegovy, Saxenda, Zepbound or Mounjaro.

What drives us:
• Science-backed solutions: Every product we create is based on proven research
• Customer focus: Your success is our priority
• Quality and trust: We maintain the highest product quality and European manufacturing standards
• Transparency: We believe in being clear and honest about what we do

We understand the complex relationship between your gut microbiome and brain in managing weight, and we're committed to developing products that support you for better results on your weight loss journey.

At the heart of our company lies a profound understanding of the obesity epidemic and the groundbreaking potential of GLP-1 medications. We witnessed firsthand the transformative impact of the anti-obesity medications (AOMs). However, these medications also come with challenges in terms of high drop-out rates, sub-optimal use and gastrointestinal side-effects affecting 40-70% of patients.

Our journey began when we realized that the key to enhancing GLP-1 therapy lay in an often-overlooked aspect of health: the gut microbiome. We came to understand that a healthy gut is not just beneficial but could be foundational to a successful weight loss journey, especially for those on GLP-1-based medications.

Driven by this insight, we assembled a team of visionaries, scientists and researchers. Our diverse backgrounds converged on a single purpose: “To enhance overall health and combat obesity through optimized gut health.”

We are pioneers at the intersection of obesity treatment and gut health. Our company is dedicated to creating a new paradigm in weight management – one that recognizes the gut microbiome as a crucial player in the success of GLP-1 and AOM therapies.

Our first product is a testament to this vision. It's designed to support GLP-1 medications, improving patients' quality of life, treatment adherence, and overall outcomes. By fostering a healthier gut microbiome, we're not just alleviating side effects; we're enhancing the body's ability to respond positively to treatment, improving lipid profiles, balancing vital nutrients, and promoting overall gut health.

We've adopted an innovative, customer-centric approach, partnering with leading obesity clinics in Switzerland and Europe to bring our solutions directly to those who need them most.

Join us as we write the next chapter in obesity treatment – where a healthy gut leads to a healthier you.

Science isn’t just a part of what we do—it’s the very foundation of our company. Our commitment to scientific excellence drives every decision we make and shapes every solution we develop.

Our scientific foundation enables us to develop innovative solutions that address real-world health problems. By combining our expertise in microbiome research with advanced scientific techniques and artificial intelligence (AI), we create therapies and products that are not only effective but also transformative for people with obesity and GLP-1 patients.